• PRM29 Translation and Validation Study of Morisky Medication Adherence Scale (MMAS)- The Urdu Version

    Nov 1, 2011, 00:00

  • PIN40 Linezolid Versus Vancomycin for Skin and Soft Tissue Infections by Methicilin-Resistant Staphylococcus Aureus- A Cost Comparison Analysis Under the Public Hospital Perspective in Brazil

    Nov 1, 2011, 00:00

  • PCN65 Cost-Effectiveness of Treating Metastatic Renal Cell Carcinoma (mRCC) Patients Whose Disease Failed on one Prior VEGF-TKI Therapy with Everolimus Compared to Treating with Best Supportive Care (BSC) Alone in Canada

    Nov 1, 2011, 00:00

  • PCN91 Pharmacoeconomic Analysis of mCRC Therapy With XELOX/FOLFOX4 Regimes With Bevacizumab or Cetuximab as the First Line Treatment in Russia

    Nov 1, 2011, 00:00

  • PCV107 Correlation of Physician-Rated Adherence with Therapeutical Outcomes in Antihypertensive Treatment- Pooled Analysis Findings from Six Valsartan Studies Including 15,583 Available Patients

    Nov 1, 2011, 00:00

  • PSS5 Visual Field Evolution in Glaucoma Patients Presenting With Different Disease Stages- Results From an Observational Study

    Nov 1, 2011, 00:00

  • NI3 Economic Evaluation in Niche Markets- The Role of the UK's Advisory Group for National Specialised Services for Rare Diseases and Disorders

    Nov 1, 2011, 00:00

  • PDB64 Criteria for Referral of Type 2 Diabetes Patients from Primary Care to Specialized Care and Vice Versa in Spain. Pathways Study

    Nov 1, 2011, 00:00

  • PDB34 Medical Treatment Costs Attributable to Obesity in Diabetic Patients in the United States

    Nov 1, 2011, 00:00

  • PCN67 Erlotinib as Second Line Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC)- Economic Modeling (EM) results

    Nov 1, 2011, 00:00

  • PDB58 How Much Do Patients with Type 2 Diabetes Value Improvements in Dosing Convenience? Results from a Conjoint Study

    Nov 1, 2011, 00:00

  • PDB3 Prevalence of Severe Osteoporosis in Daily Consultation of Rheumatology and Endocrinology Services, Costs and Quality of Life of Fragility Fractures in Mexico

    Nov 1, 2011, 00:00

  • PCV140 The Impact of National Mass Screening Program on Health Service Utilizations and Medical Expenses- In the Case of Hypertension Complications

    Nov 1, 2011, 00:00

  • RM2 Aplicacion de Modelos De Regresion Con Stata Para El Estudio Del Consumo de Recursos En Unidades De Cuidados Intensivos Neonatales

    Nov 1, 2011, 00:00

  • PRS41 Cost-Effectiveness Analysis of Immunotherapy in Patients with Grass Pollen Allergic Rhinitis

    Nov 1, 2011, 00:00

  • PHP154 Iranian Health System Decentralization Reform- A Qualitative Study of Various Levels of Autonomy Granted to Public Hospitals Affilieated with Ministry of Health in Iran

    Nov 1, 2011, 00:00

  • PMS18 Burden of Rheumatoid Arthritis in the Czech Republic – Direct and productivity Costs

    Nov 1, 2011, 00:00

  • PIH49 Otis- An Aid Tool for the Management of Itchy Scalps

    Nov 1, 2011, 00:00

  • PRS9 Disponibilidad A Pagar Por Un Metodo Efectivo Para Dejar De Fumar- Evidencias A Partir De La Encuesta Global De Tabaquismo En Adultos MÉxico 2009

    Nov 1, 2011, 00:00

  • PCV123 The Participation Decision for Lifestyle Disease Screening

    Nov 1, 2011, 00:00

  • PHP32 Market Access Variation for Lifestyle Disease Drugs in Europe

    Nov 1, 2011, 00:00

  • PSY50 Managing Pain Management- A Public Health Challenge

    Nov 1, 2011, 00:00

  • PIN10 Exchange Rate Or Power Purchase Parity For Economic Evaluation- Estimating The Costs Of Rotavirus Vaccination In A Six-Year Period Considering Data From Mexican Children

    Nov 1, 2011, 00:00

  • PRS32 Cost-Effectiveness of Omalizumab in Severe Uncontrolled Allergic Asthma Using Rct and Real-World Evidence in the Dutch Setting

    Nov 1, 2011, 00:00

  • PHP33 Impact of 2011 German Health Care Reform on Global Market Access Strategies

    Nov 1, 2011, 00:00

  • PND39 Hereditary Angioedema Health State Utility Valuation Study from the Perspective of A Representative Sample of the Australian General Public

    Nov 1, 2011, 00:00

  • IN4 Morbidity and Mortality of Community Acquired Pneumonia in Adults in Six Countries in Latin America

    Nov 1, 2011, 00:00

  • PHP141 In Search of Reform for the Greek Health Care System- Depicting the Key Opinion Leaders' Views

    Nov 1, 2011, 00:00

  • PCN10 Analisis De Minimizacion De Costos Entre El Uso De Iopromide Mediante Un Sistema De Aplicacion En Cascada (SIAC) Frente Al Uso De Otros Medios De Contraste Convencionales En Radiologia Invasiva En Colombia

    Nov 1, 2011, 00:00

  • PHP128 In Depth Analysis of Health Technology Incorporation in Brazil. Is There A Cost-Effectiveness Measure of Threshold?

    Nov 1, 2011, 00:00

  • PHP36 Perceptions of Policy Makers and Science Advice Body Staff on Science Advice in Health in Europe

    Nov 1, 2011, 00:00

  • PSY12 Comparison of the Most Common Reasons for Inpatient Admissions Among Fibromyalgia Patients on Duloxetine Versus Pregabalin

    Nov 1, 2011, 00:00

  • PCN90 Cost-Effectiveness Analysis of Erlotinib Versus Docetaxel, Pemetrexed for Second-Line Treatment of Advanced Non-Small-Cell Lung Cancer in Russia

    Nov 1, 2011, 00:00

  • PSS19 Glaucoma Management Cost as A Function of Disease Stage and Treatment Changes

    Nov 1, 2011, 00:00

  • PSY58 Responsiveness of the Treatment Satisfaction with Medicines Questionnaire (Satmed-Q) in a Longitudinal Sample of Patients with Neuropathic Pain

    Nov 1, 2011, 00:00

  • PIH5 Replacing MMR By MMRV in Mexico- Assessement of Cost-Effectiveness Based on a Dynamic Transmission Model

    Nov 1, 2011, 00:00

  • PHP116 Clincal and Economic Evidence Bases for Health Technology Assessment- A Comparison of Three Jurisdictions

    Nov 1, 2011, 00:00

  • PIN12 Analisis De Costo-Efectividad Del Uso De Proteina C Activada (PCA) En Enfermos Con Sepsis Grave Y Choque SÉptico En La Unidad De Cuidados Intensivos Del Hospital Regional 1° De Octubre Del ISSSTE

    Nov 1, 2011, 00:00

  • PIH41 Are Different Spanish Versions of Pro Measures Necessary? The Case Study of the Pedsql™ 4.0 Generic Core Scales

    Nov 1, 2011, 00:00

  • PIN89 Do Patients and Physicians Have Similar Preferences Chronic Hepatitis B Treatment Outcomes in Turkey?

    Nov 1, 2011, 00:00

  • PMD41 Drug Eluting Stent (DES) versus Bare Metal Stent (BMS) on Clinical, Humanistic and Economic outcomes- A 12-Month Prospective Observational Study

    Nov 1, 2011, 00:00

  • PIN48 Cost-Effectiveness of a Pentavalent Human-Bovine Reassortant Rotavirus Vaccine (RV5) in Japan

    Nov 1, 2011, 00:00

  • PHP130 Using Economic Evidence and Stakeholder'S Participation in Decision Making on Benefit Package of Public Health insurance in Thailand

    Nov 1, 2011, 00:00

  • PIN4 Economic Impact Of Community Acquired Pneumonia Hospitalizations In Adults In Six Countries In Latin America

    Nov 1, 2011, 00:00

  • PMS62 Improved Fatigue and Physical Function are Correlated with Health-Related Quality of Life in Psoriatic Arthritis Subjects Treated with Apremilast- Results from a Phase 2, Randomized, Controlled Study

    Nov 1, 2011, 00:00

  • PRM40 Improving the Measurement of quality of Life Based on Fuzzy Scale

    Nov 1, 2011, 00:00

  • PRS26 Direct Costs of Pneumonia in the United States- An Analysis of 2008 Medical Expenditure Panel Survey (MEPS) Data

    Nov 1, 2011, 00:00

  • PIN75 Cost-Effectiveness of Polysaccharide Pneumococcal Vaccination in People Aged 65 and Above in Poland

    Nov 1, 2011, 00:00

  • PSY11 Evaluacion Economica Del Uso Profilactico De Pegfilgastrim En Pacientes Con Quimioterapia Miloablativa Para Evitar La Neutropenia Febril

    Nov 1, 2011, 00:00

  • PRM20 Comparison of Three Methods for Measuring Multi-Morbidity According to the Use of Health Resources in Primary Health Care

    Nov 1, 2011, 00:00

  • PHP36 Historical and Future Drivers for HTA in Reimbursement Systems in Mexico and Poland

    Nov 1, 2011, 00:00

  • PHP12 Then and Now- The Evolution of International Reference Pricing Globally

    Nov 1, 2011, 00:00

  • PIN106 HIV Screening Programme in Community Pharmacies of the Basque Country

    Nov 1, 2011, 00:00

  • PRS53 Further Developments of the Asthma Life Impact Scale (ALIS)

    Nov 1, 2011, 00:00

  • PCV133 Baseline Characteristics, Intervention Modalities and Utilization of Evidence Based Medications Among ACS Patients- Does Presence of Diabetes Affect the Presentation as Well as Management Scenario for ACS? – Results from Single Centr ...

    Nov 1, 2011, 00:00

  • PSU3 Prevalence Rates of Surgical Complications Among Tuberous Sclerosis Complex Patients with Surgical Removal of Subependymal Giant Cell Astrocytoma- A Real-World National Retrospective Cohort Study

    Nov 1, 2011, 00:00

  • PCV9 Optimal Treatment Shortfalls and Worse 12-Month Outcomes for Diabetic Acute Coronary Syndrome Patients After Percutaneous Coronary Intervention in Contemporary Practi Data from the Multinational, Prospective, Antiplatelet Treatment Out ...

    Nov 1, 2011, 00:00

  • PHP10 Two Phases Study on the Perspective of Health Care Professionals on Current Mechanisms for Authorizing the Prescription of Specifically Controlled Medicines in Spain

    Nov 1, 2011, 00:00

  • PHP113 Measuring the Organizational Performance in Tennessee- A Case of Community Hospitals

    Nov 1, 2011, 00:00

  • PND29 Comparing the Cost-Effectiveness of Avonex and Betaferon in the Management of Multiple Sclerosis in Iran

    Nov 1, 2011, 00:00

  • PDB27 Projected Cost-Effectiveness of Exenatide Once Weekly Versus Exenatide Bid for the Treatment of Type 2 Diabetes in the UK

    Nov 1, 2011, 00:00

  • PSY49 Pain Management- Impact on Quality of Life

    Nov 1, 2011, 00:00

  • PCV68 Pharmacogenomic Testing for Warfarin Use in Typical outpatient Settings Lowers Health Care Costs- The Medco-Mayo Warfarin Effectiveness Study

    Nov 1, 2011, 00:00

  • PHP31 The Economic Impact of Switches of Prescription Drugs to the Over-the-Counter Status (Rx-to-OTC)- A Systematic Literature Review

    Nov 1, 2011, 00:00

  • PMH13 Differences Between Patients Undergoing Augmentation or Switching of Antipsychotic Medications During Treatment of Schizophrenia

    Nov 1, 2011, 00:00

  • IN1 Evaluacion De COSTO-Efectividad Con El Uso De Linezolid Para El Tratamiento De Infecciones Complicadas De Piel Y Tejidos Blandos

    Nov 1, 2011, 00:00

  • PND12 the Cost of Corticosteroid-associated Adverse Events in Systemic Lupus Erythematosus

    Nov 1, 2011, 00:00

  • PCV17 Cost-Effectiveness Analysis of Bosentan and Sildenafil Compared with Standard therapy in Treatment of Primary Pulmonary Arterial Hypertension in Russian Federation

    Nov 1, 2011, 00:00

  • PDB37 Injection of Long-Acting Somatostatin Analogs- A Cost Consequence Analysis for Three European Countries

    Nov 1, 2011, 00:00

  • PCV7 Tobacco Addiction Influence in Later Development of Cardiovascular Events- 3 Years Follow-up

    Nov 1, 2011, 00:00

  • PSU12 Estimating Cost and Resource Use for Whole Brain Radiation Versus Stereotactic Radiosurgery Treatments Among Brain Metastasis Patients

    Nov 1, 2011, 00:00

  • PMS6 Health Care resource Utilization of Thai Hip Fracture Patients in Public Hospital- Cost of Illness analysis at Chiangrai Hospital

    Nov 1, 2011, 00:00

  • PRM58 Methodological Reviews of Economic Evaluations in Health Care- Are They Useful?

    Nov 1, 2011, 00:00

  • PHP103 Global Health Care Reforms and Pricing, Access and Health Outcomes Strategy

    Nov 1, 2011, 00:00

  • PHP10 Medication Use Evaluation of Expensive and Broad-Spectrum Antibiotics in Songkhla Hospital

    Nov 1, 2011, 00:00

  • PCN73 Cost Effectiveness of Zoledronic Acid vs. Pamidronate or No therapy for the Treatment of Bone Metastases Secondary to Prostate Cancer

    Nov 1, 2011, 00:00

  • PCN104 Cost Minimization Analysis (CMA) of Capecitabine/Cisplatin (XP) vs. 5-Fu/Cisplatin (FP) Regimens in Advanced Gastric Cancer (AGC) Treatment in the Romanian Setting

    Nov 1, 2011, 00:00

  • PRM57 Revisiting HPV Vaccination- Why Existing CEAs Underestimate the Vaccine'S Cost-Effectiveness and Incorrectly Estimate Its Threshold Price

    Nov 1, 2011, 00:00

  • PR4 Analysis of Price Levels of Prescription Drugs and Determinants of international Price Differences between the United States and Selected European Countries

    Nov 1, 2011, 00:00

  • PRM13 Assessing the Methods for Systematic Reviews of Economic Evaluations

    Nov 1, 2011, 00:00

  • PCV43 Budget Impact of the Implementation of a Treatment Protocol for Pulmonary Arterial Hypertension in A Referral Hospital

    Nov 1, 2011, 00:00

  • PRS45 Fully Incremental Cost-Effectiveness Analysis of Available Treatment Options in the Management of Severe COPD in the UK Setting

    Nov 1, 2011, 00:00

  • PIH67 Successful Development of Annual and Long Term Prediction Models to Estimate Height Outcome following Growth Hormone (GH) Therapy in Children Using Data from KIGS – A Large Pharmacoepidemiological Survey

    Nov 1, 2011, 00:00

  • AD4 Health Outcomes as a Function of Intentional and Unintentional Non-Adherence Among Eleven Costly Conditions in the EU

    Nov 1, 2011, 00:00

  • PGI5 Irritable Bowel Syndrome with Constipation (IBS-C)- A European-Focused Systematic Literature Review of Disease Burden

    Nov 1, 2011, 00:00

  • PRS4 Effectiveness Of a Multifactorial Intervention to Improve Adherence in Patients with Chronic Obstructive Pulmonary Disease (COPD) Icepoc Study

    Nov 1, 2011, 00:00

  • PCV146 How Have Quality Checklists Improved the Quality of Published Economic Evaluations? An Example of Venous Thromboembolism (VTE) prophylaxis

    Nov 1, 2011, 00:00

  • PRS64 Exploring the Reasons Smokers Dropped Out After Enrolling at the Quit Smoking Clinic (QSC) in Malaysia

    Nov 1, 2011, 00:00

  • PRM22 Microsimulation Methods Used for Health Policy Decisions in Personalized Medicine Under Constrained Resources

    Nov 1, 2011, 00:00

  • PCV63 Direct Health Care Costs of Oral Anticoagulant Treatment in Patients with Non Valvular Atrial Fibrillation

    Nov 1, 2011, 00:00

  • PHP13 Geographical Inequalities of Home Care (Nursing) in Hungary

    Nov 1, 2011, 00:00

  • PHP77 Exploring Different HRQOL Measures as Predictors of Future Health Care Expenditures

    Nov 1, 2011, 00:00

  • PMH40 Economic Evaluation of Agomelatine for Major Depressive Disorder in Australia

    Nov 1, 2011, 00:00

  • PMH11 Psychotropic-Related Hip Fractures Around the World- A Meta-Analysis

    Nov 1, 2011, 00:00

  • PSU5 Risk of Arthritis as A Predictor for the Misdiagnosis of Chondrolysis- An International Analysis of Clinical Outcomes

    Nov 1, 2011, 00:00

  • PRS2 The Role Of RX Data in Comparative Effectiveness Research

    Nov 1, 2011, 00:00

  • PDB33 Cost of Diabetes Management to Cocoa Clinics in Ghana

    Nov 1, 2011, 00:00

  • PCN184 Trends in Chemotherapy and Biologic Treatment of US Colorectal Cancer Patients

    Nov 1, 2011, 00:00

  • PHP126 Overview of HTA Process and Implementation Among Health Stakeholders in Bosnia and Herzegovina – Survey Based Research

    Nov 1, 2011, 00:00

  • PRM2 EROS- A New Software For Early Stage Of Systematic REVIEWS

    Nov 1, 2011, 00:00

  • PCN43 Cost of HPV Associated Diseases in Saint-Petersburg

    Nov 1, 2011, 00:00

  • PHP9 Temporary Use Authorizations- The Economic and Clinical Future of Drugs Used in the French Compassionate Program

    Nov 1, 2011, 00:00

  • PCN110 Economic Evaluation of Gefitinib for First-Line Treatment of EGFR Mutation Positive Advanced Non-Small Cell Lung Cancer Patients in Greece

    Nov 1, 2011, 00:00

  • PMH63 Stay Healthy Through Game-Care Therapeutics- It's Time to Play the Game!

    Nov 1, 2011, 00:00

  • PHP86 Incorporating the Patient Perspective Into the Health Care Process- Experience from the C.A.T. Health System

    Nov 1, 2011, 00:00

  • PIN2 Facing Critical Health Events- Economic Impact Of AH1N1 Flu Epidemic In The Mexican Health Sector, 2009-2010

    Nov 1, 2011, 00:00

  • PCN64 Evaluating the Cost-Effectiveness of the Addition of Rituximab to Chemotherapy in the First Line Treatment of Follicular Lymphoma Patients in the UK

    Nov 1, 2011, 00:00

  • PRS54 Testing of a Conceptual Model of Asthma in Adolescents

    Nov 1, 2011, 00:00

  • PMH8 US Government Initiatives for Supporting Comparative Effectiveness Research, An Example from Project Libra

    Nov 1, 2011, 00:00

  • PMS2 Osteoporosis Medication Might Help reduce the incidence of Second Hip Fractures?

    Nov 1, 2011, 00:00

  • QA1 Measuring the Benefits of Health Care- Dalys and Qalys – Does the Choice of Measure Matter? A Case Study

    Nov 1, 2011, 00:00

  • PIH48 Assessment of Country-Level Health-Related Quality of Life (HRQL) Outcomes and Treatment Effect of Levonorgestrel-Releasing Intrauterine System (LNG-IUS) in Women with Idiopathic Menorrhagia

    Nov 1, 2011, 00:00

  • PMS1 Tumor Necrosis Factor Alpha Inhibitors for the Treatment of Active Ankylosing Spondylitis

    Nov 1, 2011, 00:00

  • PHP40 Promoting Efficiency of Available Capacity in A Fragmented Health System- Patients with Different Health Insurance Schemes Attended by Moh, Mexico 2006-2010

    Nov 1, 2011, 00:00

  • PRM3 Dimensionality Of Comorbidities In Heath Related Quality Of Life Comorbidity INDEX

    Nov 1, 2011, 00:00

  • PIH12 Patients with BPH in Fran Results at Six Months with Phytotherapy Versus Other Treatments

    Nov 1, 2011, 00:00

  • PSS13 Economic Burden of Psoriasis and Diabetes in Patients With Psoriasis in the United States

    Nov 1, 2011, 00:00

  • PMS5 analisis De Costo-Efectividad De Agentes Biologicos En El Tratamiento De Pacientes Con Artritis reumatoide Activa Y respuesta insuficiente A Farme Tradicionales Desde La perspectiva Del Sistema Publico De Salud En México

    Nov 1, 2011, 00:00

  • PCN188 Did Decision-Making Models from National Guidelines Change 1st Line Treatment Strategy for Patients with Metastatic Colorectal Cancer (MCRC)? The Results of Large Population Based Survey in Germany 2009

    Nov 1, 2011, 00:00

  • PCV38 Budget Impact of Changing Future Statin Use Patterns in Sweden

    Nov 1, 2011, 00:00

  • PHP23 Orphan Drug Access in Medicare Plans in the United States

    Nov 1, 2011, 00:00

  • PCN193 Using Whole Disease Modelling to Inform Economic Recommendations for the Detection, Diagnosis, Treatment and Follow-up of Colorectal Cancer

    Nov 1, 2011, 00:00

  • PIN110 Development of A Large Safety Database Using Studies Conducted During the Clinical Development and Post-Marketing of A Virosomal Aluminium-Free Hepatitis A Vaccine

    Nov 1, 2011, 00:00

  • PCV5 Thromboembolisms with Thrombopoietin Receptor Agonists- Systematic Review and Meta-Analysis of Randomized Controlled Trials

    Nov 1, 2011, 00:00

  • PHP47 Evaluation of General Public'S Expenditure on Health Products

    Nov 1, 2011, 00:00

  • PIN55 Cost-Effectiveness Analysis of Peginterferon Alfa-2A (40KD) in HBEAG-Positive Chronic Hepatitis B in Poland

    Nov 1, 2011, 00:00

  • PDB11 Economic Evaluation of Teripatide in the Management of Women with Postmenopausal Osteoporosis and High Risk of Fragility Fractures in Mexico

    Nov 1, 2011, 00:00

  • PIH30 Endometriosis-Associated Pelvic Pain Treated with Dienogest or GNRH Analogues- Cost-Utility Comparison with 5 Years Time Horizon

    Nov 1, 2011, 00:00

  • PHP127 Impact of Patient Access Schemes on NICE and SMC Guidance

    Nov 1, 2011, 00:00

  • PRM2 The Reporting of Observational Studies in Spain- Analysis Using the Strobe Statement

    Nov 1, 2011, 00:00

  • PMD78 Benefit-Risk Analysis in Absence of Clinical Eviden Deciding for Treatment of Skull Deformity in Babies Aged 5 Months

    Nov 1, 2011, 00:00

  • PCN33 Cost Analysis- Treatment of Chemotherapy-Induced Anaemia with Erythropoiesis-Stimulating Agents (ESAs) in Spain

    Nov 1, 2011, 00:00

  • PMS33 Economic Evaluation of intravenously Ibandronate for the Treatment of Postmenopausal Osteoporosis in Mexico

    Nov 1, 2011, 00:00

  • PIH42 Patients with Urinary Disorders, Evocative of BPH- What are Their Expectations in France, in Italy and in Portugal?

    Nov 1, 2011, 00:00

  • PGI16 Comparison of Treatment and Indirect Costs Between Hepatitis, Cirrhosis, Liver Transplantation and Hepatic Carcinoma- Results of the Come Study

    Nov 1, 2011, 00:00

  • PHP54 Predictors of Avoidable Emergency Room Visits Among High Cost Medicaid Enrollees

    Nov 1, 2011, 00:00

  • PCV109 Measuring Health Utility in Thai Stroke Patients

    Nov 1, 2011, 00:00

  • PCN129 Mapping the Cancer-Specific EORTC QLQ-C30 and EORTC QLQ-BR23 to the Generic EQ-5D in Metastatic Breast Cancer Patients

    Nov 1, 2011, 00:00

  • PCN115 Cost of Skeletal-Related Events (SREs) in Patients with Bone Metastases to solid Tumours Based on the Health Resource Utilisation (HRU) Collected in a Prospective European Multinational Observational Study

    Nov 1, 2011, 00:00

  • PCV29 Recent In-Hospital Mortality Trends Among Patients with Heart Failure in the Netherlands

    Nov 1, 2011, 00:00

  • PHP73 Government Reduces Public Pharmaceutical Expenditure in Hungary- Rational Decisions in Challenging Economic times?

    Nov 1, 2011, 00:00

  • PIN84 Lost in Translation- A Markov Model Cost Utility Analysis of Lopinavir/Ritonavir Vs Atazanavir + Ritonavir

    Nov 1, 2011, 00:00

  • PIN78 Cost Utility of Infant Vaccination Against Respiratory Syncytial Virus Infection in the Netherlands

    Nov 1, 2011, 00:00

  • PRS49 Economic Burden Attributable to Obesity in Adult Patients with Asthma in the United States

    Nov 1, 2011, 00:00

  • CN3 Validation Study Of The Baseline Quality Of Life As A Prognostic Indicator Of SURVIVAL- A Pooled Analysis Of Individual Patient Data From NCIC Clinical Trials

    Nov 1, 2011, 00:00

  • PHP165 A New Anti-Rebate Legislation in South Korea- Will It Work This Time?

    Nov 1, 2011, 00:00

  • PIN99 Modelling the Impact of Extended Vaccination Strategies on the Epidemiology of Pertussis

    Nov 1, 2011, 00:00

  • PRM36 Comparing the Performance of the SF-6D and EQ-5D Across Diseases

    Nov 1, 2011, 00:00

  • PMH5 Analisis De Costo Efectividad Del Manejo Farmacologico De La Esquizofrenia Recurrente En Peru Ajustado Por La Adherencia Ai Tratamiento

    Nov 1, 2011, 00:00

  • PHP122 A Comparison of HTA Recommendations Issued by Agency for Health Technology Assessment in Poland (AHTAPol) and National Institute for Health and Clinical Excellence (NICE) in the UK – Consideration of Social Implications in HTA

    Nov 1, 2011, 00:00

  • PND13 Management of Focal Epilepsy Treated by Polytherapy in Fran The Cost of Pharmaco-Resistance

    Nov 1, 2011, 00:00

  • PDB25 Real-World Outcomes of Initiating Two Different Basal Insulin Therapies Via Disposable Pens Among Patients with Type 2 Diabetes in US Employer-Sponsored Health Plans

    Nov 1, 2011, 00:00

  • PDB22 ‘Real-World' Clinical Outcomes of Exenatide Bid Compared to Insulin Glargine in Patients with Type 2 Diabetes

    Nov 1, 2011, 00:00

  • PHP99 Reimbursing Telemonitoring in Europe- Are Payers Ready?

    Nov 1, 2011, 00:00

  • PCN173 Cancer Incidence Evaluation and Pathway Identification for Treatment Course Detection Using Billing Data for Austria

    Nov 1, 2011, 00:00

  • PCV4 Comparative Efficacy of Maintenance of Sinus Rhythm Versus Rate Control Strategies in the Treatment of Atrial Fibrillation – Systematic Review and Meta-Analyses

    Nov 1, 2011, 00:00

  • PND7 Disability Progression in Patients with Relapsing Remitting Multiple Sclerosis (RRMS) Who Experience Disease Activity Despite Previous Disease Modifying Therapy

    Nov 1, 2011, 00:00

  • PGI4 Cost-Effectiveness of Esomeprazole Versus Pantoprazole in Acute and Maintenance Treatments of Reflux Esophagitis in Turkey

    Nov 1, 2011, 00:00

  • PGI22 The Extra Health Care Costs Associated Withantimicrobial Prophylaxis in Colorectal Surgical Patients- An Exploration of Profiling Data from a University Hospital in Japan

    Nov 1, 2011, 00:00

  • PSS31 Association Between Eq-5D and Dermatology Life Quality Index (Dlqi) in Patients With Chronic Hand Eczema

    Nov 1, 2011, 00:00

  • PCN20 Systematic Review of Skeletal Related Events in Breast Cancer

    Nov 1, 2011, 00:00

  • PCN93 Cost-Effectiveness of Treatment with New Agents in Advanced Non-Small-Cell Lung Cancer- A Systematic Review

    Nov 1, 2011, 00:00

  • PCN70 Cost-Effectiveness of Cetuximab and Bevacizumab in the First-Line Treatment of Metastatic Colorectal Cancer (mCRC) for Patients with Kras Wild-Type Tumours in the United Kingdom

    Nov 1, 2011, 00:00

  • PMS52 Additional Medical Costs Due to Falls/Slips at Three Teaching Hospitals in Japan

    Nov 1, 2011, 00:00

  • PND43 Validation of the Self Assessment of Treatment (SAT) Questionnaire

    Nov 1, 2011, 00:00

  • PIH1 Impacto Presupuestal Del Uso De Levonorgestrel-Uis Frente A Otros Tratamientos En Menorragia Idiopatica En Colombia

    Nov 1, 2011, 00:00

  • PRM19 Modelling the Impact of Multiple Indication Drug Launch on Total Revenue

    Nov 1, 2011, 00:00

  • PRS47 Optima Model-Based Cost-Utility Analysis of Fixed Combination Salmeterol/Fluticasone Versus Non-Fixed Combination Budesonide/Formoterol in One Pack for Bronchial Asthma Treatment

    Nov 1, 2011, 00:00

  • PMD44 Economic Evaluation of the UGT1A1 Pharmacogenetic Test to inform Dose Selection of Irinotecan-Based Chemotherapy

    Nov 1, 2011, 00:00

  • PCV113 Patient Satisfaction with Stroke Prevention in Atrial Fibrillation – Medical-Driven Interim Results of a European Survey

    Nov 1, 2011, 00:00

  • PSU13 Healthcare Resources Utilization and Associated Costs with Surgical Treatment of Dupuytrenxs Disease in Spain

    Nov 1, 2011, 00:00

  • PUK13 Prevention in Predialitic Stage has Better Results in Health

    Nov 1, 2011, 00:00

  • PRM9 What Guidance is Available for Budget Impact Analysis?

    Nov 1, 2011, 00:00

  • PND37 An Examination of Resource Utilization Among Patients with Parkinson'S Disease Treated with Rasagiline or Selegiline

    Nov 1, 2011, 00:00

  • PRM68 Outcome Measures Hierarchy for Attention-Deficit Hyperactivity Disorder

    Nov 1, 2011, 00:00

  • PMD69 Treatment of Urinary Tract infections is Common amongst Swedish Patients in Need of Chronic Catheterisation

    Nov 1, 2011, 00:00

  • PDB12 Glargine Utilisation in Russia- A Prospective Study to Evaluate Patients Switched from NPH Insulin to Insulin Glargine Compared with Those Maintained on NPH

    Nov 1, 2011, 00:00

  • PHP8 Measuring Adherence to Drug Treatment in Mexican Patients- A Systematic Review

    Nov 1, 2011, 00:00

  • PMH74 Impact of Age and Gender in the Pharmaceutical Expenditure of Anxiolytics in Primary Health Care

    Nov 1, 2011, 00:00

  • PCN50 First and Second Line Lung Cancer Treatment Utilization Patterns and associated Costs in A United States Health Care Claims Database

    Nov 1, 2011, 00:00

  • PHP33 Knowledge, Attitude, and Practices (KAP) of Food Practitioners on Hazard Analysis and Critical Control Point (HACCP) in the Kumasi Metropolis, Ghana

    Nov 1, 2011, 00:00

  • PHP157 Using the CEAC for Value Based Pricing- Don'T Change the Goalposts

    Nov 1, 2011, 00:00

  • PHP41 Monitoring of HPV Vaccination Effectiveness Within European Union

    Nov 1, 2011, 00:00

  • PRS66 Drug Use Review in Patients with Bronchial Asthma - the Introduction of the Optimization Program of Therapy

    Nov 1, 2011, 00:00

  • PRM63 Multiple Choices - How to Make Rational Decisions Across Several Interventions When Faced with Different Outcomes and Perspectives?

    Nov 1, 2011, 00:00

  • PHP4 The Appropriate Use of the Emergency Department for Paediatric Patients

    Nov 1, 2011, 00:00

  • PSY17 Retrospective Chart Review Study of the Cost of Care of Systemtic Lupus Erythematousus (Sle) in Five European Countries

    Nov 1, 2011, 00:00

  • PDB15 Use of Hypoglicemic Drugs in Serbia- Pharmacotherapeutic Versus Pharmacoeconomic Aspects

    Nov 1, 2011, 00:00

  • PHP105 Cost-Effectiveness in Drug Reimbursement Decision Making- A Toothless Tiger?

    Nov 1, 2011, 00:00

  • PUK2 Comparative Effectiveness of Investigational Compound Ferumoxytol for the Treatment of Iron Deficiency Anaemia in Chronic Kidney Disease- Systematic Review and Mixed Treatment Comparison

    Nov 1, 2011, 00:00

  • PHP137 Guidelines for Pharmacoeconomic Evaluation for Serbia

    Nov 1, 2011, 00:00

  • PMD63 Cost-Benefit analysis of CT Contrast Media (Iopromide) with Prefilled Cartridge Type Compared to Glass Bottle Type

    Nov 1, 2011, 00:00

  • PCV37 Parametric Conditional Non-Frailty Model for Recurrent Events in Persons with Type 2 Diabetes in Sweden- The Example of Myocardial Infarction

    Nov 1, 2011, 00:00

  • PCN190 Use of Surrogate Measures of Survival in Economic Evaluations of Metastatic Breast Cancer Treatments

    Nov 1, 2011, 00:00

  • PMS66 Conceptual Model of the Impact of Hip Fracture on Patients' Lives

    Nov 1, 2011, 00:00

  • PIN11 The Impact of Directly Observed Therapy (DOT) in Patients with Tuberculosis

    Nov 1, 2011, 00:00

  • PHP120 The Past As Prologue- Use of Comparative Effectiveness Reviews (CER) in National Coverage Decision Making by Medicare in the United States and Predictions on Future Use of CER

    Nov 1, 2011, 00:00

  • VA3 A Cost-Effectiveness Analysis of A 10-Valent Pneumococcal Conjugate Vaccine in Children in Six Latin American Countries

    Nov 1, 2011, 00:00

  • PIH53 Alpha Blockers, 5-Alpha Reductase Inhibitors, PDE-5 Inhibitors and Antimuscarinic Medication Use in US Patients Diagnosed with Benign Prostatic Hyperplasia, and Lower Urinary Tract Symptoms with and Without Erectile Dysfunction

    Nov 1, 2011, 00:00

  • PMD11 Treatment of Overactive Bladder and Fecal incontinence Patients from the Canary islands with Sacral Neuromodulation- Is It worth to Have regional Centers of Excellence?

    Nov 1, 2011, 00:00

  • PCN86 Cost-Effectiveness of Rituximab in Follicular Lymphoma First Line Maintenance Treatment from Public Payer Perspective in Poland

    Nov 1, 2011, 00:00

  • PDB1 Association Between Hypoglycemia and Medication Possession Ratio Among Veterans with Type 2 Diabetes Mellitus (T2DM)

    Nov 1, 2011, 00:00

  • PSS14 Burden of Disease in Patients With Severe Chronic Hand Eczema in Germany

    Nov 1, 2011, 00:00

  • PSU4 Postoperative Prevalence Rate of Subependymal Giant Cell Astrocytoma (SEGA) Diagnosis and Repeated Sega Surgery in Patients with Tuberous Sclerosis Complex- A Real-World National Retrospective Cohort Study

    Nov 1, 2011, 00:00

  • PHP42 Calidad De Vida Relacionada Con La Salud Y Apoyo Social En Estudiantes De Farmacia En Venezuela

    Nov 1, 2011, 00:00

  • PDB81 Assessment of Drug Adherence for Type 2 Diabetes Patients Using Vial or Pen Form Insulin- A Method to Adjust the Traditional Medication Possession Ratio

    Nov 1, 2011, 00:00

  • PGI1 Resource Utilization and Cost of Management of Complex Perianal Fistula in Crohn's Disease in Spain

    Nov 1, 2011, 00:00

  • PMD19 Cost-Effectiveness of Implantable Defibrillators after Myocardial Infarction Based on 8-Year Follow-up Data (MADIT II)

    Nov 1, 2011, 00:00

  • PDB80 Validation of the Updated Charlson Comorbidity Index (CCI) for Use in Patients with Diabetes or Asthma- A Comparison Study

    Nov 1, 2011, 00:00

  • PSY7 Cost Of Managing Bleeding-Related Episodes (BRE) For Romiplostim Versus Standard Of Care (SOC) In Patients With Chronic Immune Thrombocytopenia (ITP) In Mexico

    Nov 1, 2011, 00:00

  • ISPOR 14th annual European congress financial disclosure information for research presetnations

    Nov 1, 2011, 00:00

  • TP3 Patrones De Tratamiento Y Costos De atencion En Pacientes Con Artritis Reumatoide, Desde La perspectiva Del Proveedor De Servicios De Salud En México

    Nov 1, 2011, 00:00

  • PIN62 A Multidisciplinary Support program in Hepatitis C Treatment- An Economic Evaluation

    Nov 1, 2011, 00:00

  • PIH36 the Quality of Life of Patients with the Top 5 Diseases and the Way to Reflect the Burden of Diseases in Thailand- A Country-Wide Multicenter EQ-5D Measurement, 2010

    Nov 1, 2011, 00:00

  • PCN22 Safety Profile of Bevacizumab in Metastatic Colorectal Cancer

    Nov 1, 2011, 00:00

  • PCN117 Health Resource Utilisation (HRU) Associated with Skeletal-Related Events (SREs) in Patients with Bone Metastases (BMS)- Results From a Retrospective, Multinational European Study

    Nov 1, 2011, 00:00

  • PIN33 Economic Impact of the Antiretroviral Pharmacotherapy on Cost and HIV/AIDS Control in Bulgaria

    Nov 1, 2011, 00:00

  • PMH55 An Examination of Antidepressant-Related Sexual Dysfunction and Degree of Enjoyment and Satisfaction with Daily Activities, and Current Medication in Employed Patients

    Nov 1, 2011, 00:00

  • PMS26 Cost of Dupuytren Contracture in the Czech Republic

    Nov 1, 2011, 00:00

  • PMH45 Comparison of the SF-6D and the EQ-5D in Patients with Schizophrenia

    Nov 1, 2011, 00:00

  • PSU15 the Economic Burden of Post-Transplant Events in Renal Transplant Patients in UK, Italy, Netherlands, Poland and Belgium

    Nov 1, 2011, 00:00

  • PSY51 Epidemiology and Treatment Patterns of inhibitor Hemophilia in Russia- Patient-reported Data

    Nov 1, 2011, 00:00

  • PRM44 The First Research- Assessment of the WTP Threshold for QALY by Contingent Valuation Method in Russia

    Nov 1, 2011, 00:00

  • PCN113 Cost-Utility Analysis of Combination Therapy of Pegylated Liposomal Doxorubicin(PLD) and Carboplatin for Korean Women with Platinum-Sensitive Ovarian Cancer

    Nov 1, 2011, 00:00

  • PDB61 Assessment of Quality of Life in Children and Adolescents with Type 1 Diabetes Mellitus

    Nov 1, 2011, 00:00

  • PMH38 Buprenorphine/Naloxone Versus Buprenorphine and Methadone in Heroin Addiction Detoxification- An Italian Cost-Utility Analysis

    Nov 1, 2011, 00:00

  • PHP146 Current Status and Trends in Performance-Based Schemes Between Health Care Payers and Manufacturers

    Nov 1, 2011, 00:00

  • PRS24 Impact Of Age and Patient Co-Morbidities on Community Acquired Pneumonia (CAP) Related Costs at the Hospital Setting in a Well Defined Area Of Barcelona (Badalona, Spain)

    Nov 1, 2011, 00:00

  • PHP111 ISPOR- Awareness, Drivers and Barriers to Involvement of UK Cancer Network Stakeholders

    Nov 1, 2011, 00:00

  • PMH51 Measuring Relapse After Substance Abuse Treatment- A Proportional Hazard Approach

    Nov 1, 2011, 00:00

  • PIN92 Patient Reported Outcomes Among Chronic Hepatitis C Patients Re-Treated with Peginterferon Alfa-2A/Ribavirin After Non-response to Peginterferon Alfa-2B/Ribavirin in Spain

    Nov 1, 2011, 00:00

  • PND55 The Predictors of Health-Related Quality of Life in Pediatric Epilepsy- A Systematic Review

    Nov 1, 2011, 00:00

  • PCV117 Clinical and Patient-Reported Outcomes of Triple Combination of Olmesartan Medoxomil (OM), Amlodipine Besylate (AML) and Hydrochlorothiazide (HCT) in Hypertensive Patients

    Nov 1, 2011, 00:00

  • NI1 The UK Nice Single Technology Appraisal Process- A Qualitative Study Based on Manufacturers' Submissions

    Nov 1, 2011, 00:00

  • PCV75 Cost-Effectiveness of Optimizing Use of Statins in Australia- Using Outpatient Data from the REACH Registry

    Nov 1, 2011, 00:00

  • PRS50 The Dutch 1-Year Resource Use Results from the Experience Study, an International Registry of Real-World Outcomes for Asthma Patients Treated with Omalizumab

    Nov 1, 2011, 00:00

  • PCN18 Intermittent Versus Continuous Chemotherapy for First-Line Treatment of Unresectable Metastatic Colorectal Cancer (CCRm)- Systematic Review and Meta-Analysis

    Nov 1, 2011, 00:00

  • PMD64 The Effect of Supplementary Fees on the Diffusion of Medical Devices in the German System of Diagnosis related Groups (G-Drg)- The Case of Drug-Eluting Stents in Patients with Acute Myocardial Infarction

    Nov 1, 2011, 00:00

  • HT2 Value Based Pricing- One Threshold too Far for the United Kingdom

    Nov 1, 2011, 00:00

  • PDB16 First Results of the Post-Marketing Survey of Vildagliptin in France

    Nov 1, 2011, 00:00

  • PIN27 Cost analysis of the Consumed Oral Antibiotics in a Tertiary Care

    Nov 1, 2011, 00:00

  • PCN19 The Broader Burden of HPV-related Disease in England- A Preliminary Analysis

    Nov 1, 2011, 00:00

  • PIH45 Burden of Herpes Zoster and Post-Herpetic Neuralgia- Findings from a Cross-Sectional Patient Reported Outcomes Study

    Nov 1, 2011, 00:00

  • PND68 Social Economic Burden and Health-Related Quality of Life in Patients with Rare Diseases in Europe (BURQOL-RD Project)- Methods of Selection of 10 Diseases for A European Survey

    Nov 1, 2011, 00:00

  • PMS45 Cost-Utility and Budget Impact Analysis of Certolizumab Pegol Plus Methotrexate for the Treatment of Moderate-to-Severe Active Rheumatoid Arthritis in Greece

    Nov 1, 2011, 00:00

  • PCV54 First-Year Direct Medical Cost of Newly Diagnosed Stable Angina in Hong Kong

    Nov 1, 2011, 00:00

  • PCN75 Epidemiologic and Economic Impact of HPV (6/11/16/18) Vaccination in Turkey

    Nov 1, 2011, 00:00

  • PMH3 Cost-Effectiveness Of Paliperidone Palmitate For The Treatment Of Schizophrenia In MÉxico

    Nov 1, 2011, 00:00

  • PCN99 Cost-Effectiveness of Dasatinib versus High-Dose Imatinib and Nilotinib in Patients with Chronic Myeloid Leukaemia Resistant to Standard-Dose Imatinib in Portugal

    Nov 1, 2011, 00:00

  • RM4 Factores Predictores De Obstrucciones Coronarias Significativas En Pacientes Adultos Con CineangiocoronariografÍas Realizadas En Uruguay, Financiadas Por El Fondo Nacional De Recursos

    Nov 1, 2011, 00:00

  • PMH9 Prescribing Patterns and Cost of Drugs for Alzheimer's Disease

    Nov 1, 2011, 00:00

  • PRM27 Modelling the Brazilian Extended Consumer Price Index for Pharmaceutical Products- Comparison Between Exponential Smoothing and Box-Jenkins Methods

    Nov 1, 2011, 00:00

  • PRM23 General Methodological Issues in Cost-Effectiveness Analysis Inspired by the Assessment of Dasatinib, Nilotinib and Imatinib for Chronic Myeloid Leukaemia

    Nov 1, 2011, 00:00

  • PMD28 Cost-Effectiveness Analysis of Three Leprosy Case Detection Methods in Northern Nigeria

    Nov 1, 2011, 00:00

  • PCN139 Human Papilloma Virus and Cervical Cancer - Knowledge and Interest of Man and Woman

    Nov 1, 2011, 00:00

  • PCN76 Cost-Effectiveness Analysis of Compliance with Clinical Practice Guidelines in Sarcoma Treatment- An Economic Evaluation in Two European Regions

    Nov 1, 2011, 00:00

  • PCN142 Methodological Limitations of Patient-Reported Outcome Measures (PROMs) in oncology- A Meta-Review

    Nov 1, 2011, 00:00

  • Instructions for Authors

    Nov 1, 2011, 00:00

  • PCN66 A Cost and Outcomes Analysis of Bevacizumab plus Folfiri Versus Cetuximab Plus Folfiri for the Treatment of First-Line Metastatic Colorrectal Cancer Patients from the Brazilian Private Payer Perspective

    Nov 1, 2011, 00:00

  • PCV81 Cost-Effectiveness of Ticagrelor Versus Clopidogrel in Patients with Acute Coronary Syndrome- Results from the Plato Study- A Canadian Analysis

    Nov 1, 2011, 00:00

  • PHP112 Inter-Individual Country Variability in Monoclonal Antibodies (MABS) Reimbursement and Coverage Following EMA Approval

    Nov 1, 2011, 00:00

  • PCV72 Long-Term Cost Effectiveness Analysis of Ticagrelor in Patients with Acute Coronary Syndrome from a Polish Health Care Perspective

    Nov 1, 2011, 00:00

  • PHP136 Radiology Diagnostics and Interventional Radiology Services Utilization Patterns and Economic Consequences Analysis in a Large Tertiary Care University Hospital – Three Year Trends

    Nov 1, 2011, 00:00

  • PCN46 Cost of Metastatic Prostate Cancer Treatment in the 12 Months Following Diagnosis per Patient in Russian Federation

    Nov 1, 2011, 00:00

  • PIN44 Cost-Effectiveness of Quadrivalent HPV Vaccination in Germany Using A Dynamic Transmission Model

    Nov 1, 2011, 00:00

  • PGI11 Cost Analysis of Antihelicobacter Therapy of Gastric and Duodenum Ulcer in Ukraine

    Nov 1, 2011, 00:00

  • MO2 Extrapolation in Oncology Modelling- Novel Methods for Novel Compounds

    Nov 1, 2011, 00:00

  • QA3 Costo-Efectividad De Dabigatran Versus Warfarina En El Manejo De La Fibrilacion Auricular En Colombia

    Nov 1, 2011, 00:00

  • PCN34 Cost Analysis of Anemia Treatment with Erythropoiesis-Stimulating Agents (ESAs) in Cancer Patients Receiving Chemotherapy in Italy

    Nov 1, 2011, 00:00

  • PCN52 Economic Impact of Healthcare Resource Utilisation Patterns Among Patients Diagnosed with Advanced Melanoma in the UK, Italy, and Fran Results From a Retrospective, Longitudinal Survey (Melody Study)

    Nov 1, 2011, 00:00

  • PCV92 Cost Utility of Ranolazine in the Symptomatic Treatment of Patients with Chronic Angina Pectoris in Spain

    Nov 1, 2011, 00:00

  • PCN1 Burden of Hospitalization in Patients with Advanced Lung Cancer in France and Germany

    Nov 1, 2011, 00:00

  • PCV98 Estimating Willingness to Pay for Hypertension Outpatient Benefit Packages

    Nov 1, 2011, 00:00

  • PHP60 Drug-related Morbidity – Modeling the Cost-of-Illness in Sweden Using Pharmacists' Opinion

    Nov 1, 2011, 00:00

  • PRS63 Faciliators and Barriers Associated with the Use of Pharmacological – Behavioral Combination Therapy to Smoking Cessation

    Nov 1, 2011, 00:00

  • PMD29 A1CNow® as Ambulatory Monitoring of Glycated Hemoglobin in Diabetic Type 2 (DM2) Patients- Brazilian Economic Modeling

    Nov 1, 2011, 00:00

  • PMH39 Cost Effectiveness of A Collaboratieve Care Stepped intervention for Anxiety Disorders in the Primairy Care Setting

    Nov 1, 2011, 00:00

  • PND31 A Modelled Economic Evaluation of Firazyr® (Icatibant) for Symptomatic Treatment of Acute Attacks of Hereditary Angioedema (HAE) in Adults with C1-Esterase-Inhibitor (C1-INH) Deficiency

    Nov 1, 2011, 00:00

  • PGI12 Gastroesophageal Reflux Disease Patients Who Switched from a Branded Proton Pump Inhibitor to a Generic One and Vice Versa- A Cost Comparison

    Nov 1, 2011, 00:00

  • PCN140 Rural - Urban Differences in Fatalistic Beliefs About Cancer Prevention

    Nov 1, 2011, 00:00

  • PCV47 Analysis of Transient Ischemic Attack-Related Clinical Outcomes, Health Care Utilization and Cost Burden of Patients with Non-Valvular Atrial Fibrillation

    Nov 1, 2011, 00:00

  • CN3 Cost Effectiveness of Liposomal Doxorubicin Versus Paclitaxel for the Treatment of Aids-Ks

    Nov 1, 2011, 00:00

  • PMH60 Factors Associated with Health-Related Quality of Life in Alcohol Dependent Patients

    Nov 1, 2011, 00:00

  • PCV128 A Real World Evaluation to Describe the Characteristics, Outcomes and Resource Use Associated with Patients Being Managed by a Secondary Care Based Anticoagulation Service

    Nov 1, 2011, 00:00

  • PMH2 The COST-Effectiveness Of Paliperidone Palmitate Compared To Olanzapine Pamoate In The Treatment Of Schizophrenia In Sweden

    Nov 1, 2011, 00:00

  • PCV3 Thromboprophylaxis Use and Venous Thromboembolism, Major and Minor Bleeding Event Analysis in Hospitalized Medically Ill Patients

    Nov 1, 2011, 00:00

  • PRM7 Using Probabalistic Sensitivity Analysis in Budget Impact Models to Reduce Uncertainty and Improve Decision-Making

    Nov 1, 2011, 00:00

  • PMS43 Cost-Minimization Analysis of Collagenase Clostridium Histolyticum Compared with Fasciectomy in Patients with Dupuytren'S Contracture in Portugal

    Nov 1, 2011, 00:00

  • PSS36 Demonstrating Conceptual Equivalen Translation of the Cu-Q2Ol From Italian into English

    Nov 1, 2011, 00:00

  • PSY24 Pregabalin is Cost-Saving in Comparison with Gabapentin Treated Patients when Added to Existing Therapy in the Management of Painful Radiculopathies

    Nov 1, 2011, 00:00

  • PSS33 Estimation of Meaningful Change on the Skindex-29 and Dermatology Life Quality Index in Patients With Chronic Hand Eczema

    Nov 1, 2011, 00:00

  • PIH68 Studying Heterogeneity in Treatment Response in Women with Idiopathic Menorrhagia Treated with Levonorgestrel-Releasing Intrauterine System (LNG-IUS)- Application of Innovative Methods to Identify Differential Response

    Nov 1, 2011, 00:00

  • PMS34 Cost-Effectiveness Analysis of Bio- Hyaluronic Acid (HA) in Patients with Knee Osteoarthritis in Mexico

    Nov 1, 2011, 00:00

  • PIH13 Generalising the Output of Rotavirus Vaccination Impact Studies- What Can We Learn?

    Nov 1, 2011, 00:00

  • PCN144 Health-Related Quality of Life in Prostate Cancer – One Year Follow-up and Comparison with General Population Norms

    Nov 1, 2011, 00:00

  • PHP150 Pharmaceutical Pricing Under Uncertainty- Risk-Sharing Contracts

    Nov 1, 2011, 00:00

  • PMH4 Economic Assessment Of Major Depressive Disorder Treatment Under Different Therapeutic Classes At Issste

    Nov 1, 2011, 00:00

  • PIN61 Cost of Virologic Response with Two Active Drugs in the Optimized Background Therapy with Etravirine, Raltegravir, and Maraviroc in the Brazilian National AIDS Program

    Nov 1, 2011, 00:00

  • PMH15 Mortality in relation to Disease Severity in Subjects with Dementia

    Nov 1, 2011, 00:00

  • PHP27 Diffusion of Innovations in Health Care- Does the Dual Market Phenomenon Exist?

    Nov 1, 2011, 00:00

  • PCN7 The Incidence and Outcome of Febrile Neutropenia in Different Chemotherapy Regimens for Cancer Patients in Belgium

    Nov 1, 2011, 00:00

  • PCN7 Impacto Presupuestario Del Tratamiento En Primera LÍnea Para CÁncer Colorrectal MetastÁsico Basado En XELOX + anti-VEGF o XELOX + anti-EGFR

    Nov 1, 2011, 00:00

  • PHP12 The Ratio of Public Reimbursement and Patients' Co-Payment in the Financing of Spa Services in Hungary

    Nov 1, 2011, 00:00

  • PIN47 Cost-Effectiveness of Telbivudine in First Line Treatment of HBEAG-Negative Patients with Chronic Hepatitis B (CHB) in the Turkish Healthcare Setting

    Nov 1, 2011, 00:00

  • PCN8 Cost-Effectiveness Analysis of an Opioid in Combination with Gabapentin Versus Monotherapy for the Treatment of Neuropathic Pain

    Nov 1, 2011, 00:00

  • PIN105 Financial Support for HIV/AIDS Prevention, Care and Treatment in Thailand

    Nov 1, 2011, 00:00

  • PCN62 Costs and Consequences of HPV Vaccination in Thailand- Results of a Prevalence Based Model

    Nov 1, 2011, 00:00

  • PCN59 Economics of Primary Prophylactic G-CSF Use in Preventing Neutropenia in Elderly Breast Cancer Patients Receiving Chemotherapy- Are Short-Term Increase in Costs Necessarily Bad?

    Nov 1, 2011, 00:00

  • MT3 A Bayesian Approach to Model Selection procedures within Mixed Treatment Comparison Framework

    Nov 1, 2011, 00:00

  • PMD6 Efficacy and Safety of Artificial Disc Arthroplasty Compared to Surgical Fusion for Single Level Cervical and Lumbar Degenerative Disc Disease- A Bayesian Meta-analysis

    Nov 1, 2011, 00:00

  • PIN19 Pharmacoeconomic Analysis of Pegylated Interferon Alfa Use in Chronic Hepatitis C

    Nov 1, 2011, 00:00

  • PMD48 An Economic Evaluation of the Heartware Ventricular assist Device in the NHS

    Nov 1, 2011, 00:00

  • PSS11 Ranibizumab and Bevacizumab for the Treatment of Age-related Macular Degeneration- A Systematic Review and Economic Evaluation

    Nov 1, 2011, 00:00

  • PHP75 The Cost Per Day of Intensive Care Units (ICU) in Fran The CRRÉA Study

    Nov 1, 2011, 00:00

  • PSY2 Coexistence of Immuno-Mediated Inflammatory Diseases- an Analysis of the Quebec Administrative Health Databases

    Nov 1, 2011, 00:00

  • PMH61 A Descriptive Analysis of Atomoxetine Utilization in Attention Deficit/Hyperactivity Disorder (ADHD) the United Kingdom and Italy

    Nov 1, 2011, 00:00

  • PIN72 Cost-Effectiveness of Rotavirus Immunization in Vietnam- Results and Challenges

    Nov 1, 2011, 00:00

  • PIN108 Sustained Virological Response as Patient-Relevant Endpoint in Hepatitis C?

    Nov 1, 2011, 00:00

  • PDB69 Prescription Pattern Study of Type 2 Diabetes Mellitus in Iran

    Nov 1, 2011, 00:00

  • PIH51 What Do Patients with Rare Diseases Experience in the Medical Encounter? Exploring Patient-Physician-Interaction Patterns, Its Antecedents and Its Consequences

    Nov 1, 2011, 00:00

  • PHP61 Modeling Pharmaceutical Costs in Primary Health Care According to Chronic Conditions

    Nov 1, 2011, 00:00

  • PSS34 Qualitative Grounding for A New Patient Assessment Measure in Ophthalmology- The Functional Assessment of Visual Tasks (Vistas)

    Nov 1, 2011, 00:00

  • PHP52 Inequalities in the Utilization of Home Hospice Services in Hungary

    Nov 1, 2011, 00:00

  • PCV49 Evaluating the Management of the Rehabilitation Unit in A Tertiary Referral Hospital in Spain- A Cost-Analysis Study

    Nov 1, 2011, 00:00

  • PMD27 Cost-Effectiveness Analysis of Cardiac Resynchronization Therapy in Patients with Asymptomatic to Mild Heart Failure Based on the European Cohort of the reverse Study from the Spanish Health System Perspective

    Nov 1, 2011, 00:00

  • PMH52 Relationship Between Psychopathology and Self-Rated EQ-5D Health States Among Patients With Schizophrenia

    Nov 1, 2011, 00:00

  • PGI19 Stress Ulcer Bleeding Prophylaxis with Proton Pump Inhibitors, H2 Receptor Antagonists or Sucralfate- A Cost-Effectiveness Analysis

    Nov 1, 2011, 00:00

  • PMH10 Exposure to Antipsychotic Medications During Four Year Periods Following Treatment Initiation among Children Under Six Years Old

    Nov 1, 2011, 00:00

  • RM3 A Comparison Between Markov Chains and System Dynamics Modeling for the Estimation of Metabolic Syndrome Costs in a Public Health Care Delivery Organization in MÉxico

    Nov 1, 2011, 00:00

  • PCV112 A Comparison of European Health Care Systems on Stroke Prevention in Atrial Fibrillation – Interim Results of a Patient Satisfaction Survey

    Nov 1, 2011, 00:00

  • PMS72 Assessment of Prior Use of Prescribed Pain Medications Among Elderly Patients Who Initiated Duloxetine

    Nov 1, 2011, 00:00

  • RS1 Literature Review On Patient Access Schemes, Flexible Pricing Schemes And Risk Sharing Agreements For Medicines

    Nov 1, 2011, 00:00

  • PIN42 Methodological Decisions in Economic Evaluations of Childhood Influenza Vaccination- Findings from a Literature Review

    Nov 1, 2011, 00:00

  • PHP124 Personalized Decision Making in Cancer Medicine? Systematic Overview of HTA Procedures and Specific Approaches in Ten Countries Across Four Continents

    Nov 1, 2011, 00:00

  • PHP6 Regional Variability in the Generic Antidepressant Market in Spain

    Nov 1, 2011, 00:00

  • PRS23 High Cost Cystic Fibrosis Patients as Identified in a Us Claims Database- A Closer Look at the Tail

    Nov 1, 2011, 00:00

  • PUK5 Mixed Treatment Comparisons of Immunosuppressants Following Renal Transplant

    Nov 1, 2011, 00:00

  • PMD23 Characterization of Focal Liver Lesions by Contrast-Enhanced Ultrasound in the Netherlands- An Economic Evaluation

    Nov 1, 2011, 00:00

  • PCN101 A Cost-Effectiveness Analysis for Second-Line Treatment of Relapsed/Refractory (RR) Multiple Myeloma (MM) in the United Kingdom

    Nov 1, 2011, 00:00

  • PSY29 Economic Evaluation of Capsaicin Patch 8% in the Treatment of Neuropathic Pain in Austria

    Nov 1, 2011, 00:00

  • PMD2 Clinical Decision Rules for Adults with Minor Head injury- A Systematic Review

    Nov 1, 2011, 00:00

  • PMH37 Cost-Minimisation Analysis of Asenapine Monotherapy Versus Other Antipsychotics in Bipolar I Disorder in Two Nordic Countries

    Nov 1, 2011, 00:00

  • PCN27 Budget Impact Analysis for Chronic Mieloid Leukemia Therapy in Bulgaria

    Nov 1, 2011, 00:00

  • PMD53 Pulmonary Vein isolation for the Treatment of Paroxysmal AF- Time reduction and productivity Gain with “anatomically-Designed” Cathethers Compared to “Point by Point” Catheters

    Nov 1, 2011, 00:00

  • PMD34 Cost Effectivness of Ambulatory Cardiac Monitor versus Holter

    Nov 1, 2011, 00:00

  • PRS2 Costos De atencion Medica atribuibles Al Consumo De Tabaco En México

    Nov 1, 2011, 00:00

  • PCV127 Time to Initiation of Oral Antihyperglycaemic and Statin Therapy in Patients with Newly Diagnosed Type 2 Diabetes Mellitus

    Nov 1, 2011, 00:00

  • PIH35 The Measurement and Valuation of Health Status Using EQ-5D in Brazil- A Systematic review

    Nov 1, 2011, 00:00

  • PMH69 Deprivation and Use of Atipycal Antipsychotics in Schizophrenia

    Nov 1, 2011, 00:00

  • PCV15 Guidelines Adherence and Hypertension Control in Patients Suffering from Cardiovascular Disease

    Nov 1, 2011, 00:00

  • PCV30 Heart Failure (Re)Admissions in the Netherlands- Rates, Length of Stay and Costs

    Nov 1, 2011, 00:00

  • PHP156 Novel Drug Reimbursement Models- Lessons and Implications from Cancer Drug Access Schemes

    Nov 1, 2011, 00:00

  • PRS72 How Much Would the Universal Uptake of Gold Recommendations for Italian COPD Patients Cost?

    Nov 1, 2011, 00:00

  • PDB49 Resource Use in Patients with Type 2 Diabetes (T2D) Who Initiated Exenatide BID (EXBID) or Starter Insulin (INS) Therapy- 6-Month Data from Choice

    Nov 1, 2011, 00:00

  • PND11 Budget Impact Analysis of First-Line Treatment for Relapsing – Remitting Multiple Sclerosis in Spain

    Nov 1, 2011, 00:00

  • PCV28 Control of Hypertension in Spain- A Systematic Review and Meta-Analysis of 76 Epidemiological Studies on 341,632 Participants

    Nov 1, 2011, 00:00

  • PHP96 Mitigating Emergency Department Over-Crowding Utilizing Focused Operations Management Tools

    Nov 1, 2011, 00:00

  • PIN24 Potential Costs Associated with New Direct Acting Antiviral (DAAs) Therapy for Untreated Chronic Hepatitis C Genotype 1 Infection in the Veterans Health Administration

    Nov 1, 2011, 00:00

  • PSY53 Changes in Concomitant therapy for Weight-related Illness Following Initiation of Weight Loss Pharmacotherapy

    Nov 1, 2011, 00:00

  • DA3 The Power of Assumptions

    Nov 1, 2011, 00:00

  • PDB75 Analysis of the Medicines Pricing Procedure in the Republic of Macedonia

    Nov 1, 2011, 00:00

  • PSY31 Cost-Effectiveness of Tapentadol Prolonged-Release (Pr) Compared to Oxycodone Controlled Release (Cr) in Patients with Chronic Severe Non-Cancer Pain in Ireland

    Nov 1, 2011, 00:00

  • PRM16 Covariance Structures for Modeling Longitudinal Data

    Nov 1, 2011, 00:00

  • PIH55 Necessity of Admissions and Hospitalizations in Selected Teaching University Affiliated and Private Hospitals of Shiraz, Iran in 2007

    Nov 1, 2011, 00:00

  • PHP148 Global Pharmaceutical Risk-Sharing Agreement Trends in 2010 and 2011

    Nov 1, 2011, 00:00

  • PMS59 Inadequate Pain Relief in Knee Osteoarthritis and Patient Reported outcomes- A Survey of Osteoarthritis Real World Therapies (SORT) in the United Kingdom

    Nov 1, 2011, 00:00

  • PHP152 The Administrative Burden of Patient Access Schemes in the Changing UK Health Care System- A Follow Up Study

    Nov 1, 2011, 00:00

  • PDB14 Assessment of the Clinical and Economic Benefits of Adequate Insulin Initiation and Intensification in People with Type 2 Diabetes Mellitus

    Nov 1, 2011, 00:00

  • PMD82 Drug Eluting Balloon for the Treatment of peripheral Artery Disease- A Cost-Effectiveness analysis in Italy

    Nov 1, 2011, 00:00

  • PRS6 Cost-Effectiveness of Fluticasone Furoate Compared with Mometasona Furoate for the Primary Treatment of Allergic Rhinitis Patients

    Nov 1, 2011, 00:00

  • PMS4 Efficacy and Effectiveness of Collagenase Clostridium Histolyticum for Dupuytren'S Contracture

    Nov 1, 2011, 00:00

  • PHP57 Centralized Drug Assessment in Catalonia- Where We Have Gone so Far?

    Nov 1, 2011, 00:00

  • PCN81 A Cost-Effectiveness Analysis of Adjuvant Trastuzumab Regimens in Early HER2/NEU-Positive Breast Cancer in Colombia

    Nov 1, 2011, 00:00

  • PHP138 Intangible Capital and Return on Assets in the Pharmaceutical Industry

    Nov 1, 2011, 00:00

  • PSU16 Minimally Invasive Surgery in Total Hip Arthroplasty- A Cost-Effectiveness Analysis

    Nov 1, 2011, 00:00

  • MO4 Outcomes Beyond Health

    Nov 1, 2011, 00:00

  • PCN198 Review of Economic Assessments of Emerging Genomic Technologies in Oncology

    Nov 1, 2011, 00:00

  • PRS1 Budget Impact analysis of Fluticasone Furoate (FFNS) in Treatment of Allergic Rhinitis Patients in Mexico

    Nov 1, 2011, 00:00

  • PRM18 Sensitivity Analysis in Multi-Criteria Decision (MCDA) Models for Benefit-Risk Assessment

    Nov 1, 2011, 00:00

  • PDB30 Assessment of the Impact of the New Antidiabetic Treatment with Vildagliptin to Change the Total Costs on Diabetes Type 2

    Nov 1, 2011, 00:00

  • PHP42 Drug Consumption in Bosnia and Herzegovina - Comparison to Neighboring Country

    Nov 1, 2011, 00:00

  • PMH59 Employment Status and Self reported Quality of Life in Chinese Patients Receiving Treatment for Major Depressive Disorder

    Nov 1, 2011, 00:00

  • PND32 Cost-Utility Analysis of Ropinirole in Parkinson'S Disease (PD) Treatment

    Nov 1, 2011, 00:00

  • PCV120 Quality of Life in Chronic Symptomatic Heart Failure Patients in Spain, insight from the Inoescaro Study

    Nov 1, 2011, 00:00

  • PHP145 the Burden of Evidence in the Pharmaceutical Appraisal process

    Nov 1, 2011, 00:00

  • PMS11 review of the Studies on Economic Evaluation of Treatment for Postmenopausal Osteoporosis

    Nov 1, 2011, 00:00

  • PMD5 Diagnostic Accuracy of Clinical Characteristics following Minor Head injury- A Systematic review and Meta-analysis

    Nov 1, 2011, 00:00

  • PIH64 Female Urinary Incontinence in Germany– Cost Explosion Tomorrow?

    Nov 1, 2011, 00:00

  • PHP104 Identifying Factors Influencing Drug Reimbursement in Scotland

    Nov 1, 2011, 00:00

  • PMS54 The Clinical and Economic Burden of Poor Adherence with Osteoporosis Medications in Ireland

    Nov 1, 2011, 00:00

  • PCN119 Lack of Data for Indirect Costs Associated With Treatment of Early Breast Cancer

    Nov 1, 2011, 00:00

  • PDB10 Achieving Target Goals in Patients with T2DM Treated with Exenatide Once Weekly or Insulin Glargine- A Retrospective Analysis of the Number-Needed-To-Treat

    Nov 1, 2011, 00:00

  • PMS68 Measuring the Health-Related Quality of Life in Patients with Rheumatoid Arthritis Treated with Adalimumab in Gree Comparing the Results of One Generic (EQ-5D) and One Disease-Specific (HAQ) Instrument

    Nov 1, 2011, 00:00

  • PSY41 Health Status and Health-Related Quality of Life Reported by Females with Bleeding Disorders from the Canadian National Haemophilia Registry

    Nov 1, 2011, 00:00

  • PHP142 Landmark CER Study Methods Review

    Nov 1, 2011, 00:00

  • PHP5 Analysis of Linked Medical Claims Data for Preinvestigation in Modeling Studies

    Nov 1, 2011, 00:00

  • PHP107 Clinical Trial Activity in Gree Opportunities Missed, Soon to be Forgone?

    Nov 1, 2011, 00:00

  • PRS6 Mortality Trends in Patients with Chronic Obstructive Pulmonary DISEASE- Data from a Structured Literature Review

    Nov 1, 2011, 00:00

  • PDB51 A Comparison of Insulin Adherence in Patients with Type 2 Diabetes Initiating Therapy with Insulin Detemir Flexpen® or NPH Insulin in a Vial

    Nov 1, 2011, 00:00

  • PRS39 Cost-Effectiveness of Roflumilast in Combination with Bronchodilator Therapies in Patients with Severe and Very Severe COPD in Switzerland

    Nov 1, 2011, 00:00
  • «
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136 (current)
  • 137
  • 138
  • 139
  • 140
  • »